DOI: https://doi.org/10.26641/2307-0404.2018.1(part1).127208

Efficacy of combination of antihistaminic agents and blocker of leukotriene receptors in the treatment of pollinosis exacerbation with bronchial asthma attacks.

Y. Dytyatkovska, I. Rodkina, M. Yevtushenko, L. Grybanova, Y. Bendetska, A. Romanova, I. Koretskaia

Abstract


We have been observing 60 pollinosis patients at the age of 19 to 64 years with clinical manifestations of rhinitis, conjunctivitis, bronchial asthma. The study was conducted in the design of parallel groups. All patients were divided into 2 clinical groups (main and control), depending on the treatment regimen. The main group included 40 patients who received a combined drug Glencet Advance 1 tab. in the evening for 1 month. 20 patients included in the control group received symptomatic local therapy (eye drops, IGCC), β2-short-acting agonists. Results: integral assessment of symptoms in the main group before treatment was 11.50±0.13 and significantly decreased after treatment to 0.68±0.14 (p<0.001). In the control group differences were much less expressed from 11.15±0.22 before treatment to 3.05±0.29 (p<0.001) after treatment. FEV1 (%) in the main group has been improving more intensively (from 55.5±1.14 to 90.7±1.31 (p<0.01). PEF has been improving from 187.5±4.34 l/sec to 406.3±10.73 (p<0.001). In the control group these changes are less expressed for FEV1 (%) from 56.2±1.72 to 78.5±2.18 (p<0.001). PEF l/sec – (from 195.0±6.75 to 320.0±12.50 (p<0.01)). The histamine level decrease (ng/ml) in the main group was reliable – from 4.29±0.52 to 1.40±0.3 (p<0.5). In the control group – from 3.00±0.33 to 2.82±0.31 (there is no veracious data). Change of the total IgE level in serum: veracious decrease from 487.2 to 367.8 in the main group, no veracious decrease in the control group. Conclusions: the use of combined therapy with antihistamines and antileukotriene drugs in patients with pollinosis gives a good clinical effect, which is confirmed by a veracious decrease of histamine and total IgE levels in blood serum, as well as by veracious improvement in FEV1 and PEF.

Keywords


pollinosis; specific immunotherapy; respiratory function; spirometry; bronchial asthma; antileukotrienes

References


Lopatin AS, Petrov VI, Slizova TA, Ponomareva YuV. [Allergic rhinitis: pharmacoeconomic aspects]. At­mosfera. 2003;4:47-50. Russian.

AleshinaRM.[Specific immunotherapy is an ef­fective method of basic treatment for atopic bronchial asthma]. ImunologIya ta alergologIya. 1998;1/2:115-9. Russian.

Bulgakova VA, Balabolkin II, Ksenzova LD. [Mo­dern trends in pharmacotherapy of allergic rhinitis in children]. Voprosyi sovremnoy pediatrii. 2007;6:85-91. Russian.

Goryachkina LA.[Modern antihistamines in the treatment of allergic diseases]. RinologIya. 2002;1:70-76. Russian.

Guschin IS. [Pathophysiology of allergy]. Ros. rinologiya. 2004;1:6-22. Russian.

Drannik GN [Clinical Immunology and Allergo­logy]. Kyiv, OOO «Poligraf plyus». 2010:1-552. Russian.

Emelyanov AV [Modern ideas about the diag­nosis and treatment of allergic rhinitis]. Lechaschiy vrach. 2003;3:4-11. Russian.

Zaykov SV. [Are there approaches to the diagno­sis and treatment of allergic rhinitis inUkraineand the EU?]. Klinichna Imunologiya. Alergologiya. In­fekto­logiya. 2007;2:13-16. Russian.

Zaykov SV. [Modern ideas about the treatment of pollinosis]. Klinich. Imunologiya. Alergologiya. Infekto­logiya. 2008;3(14):49-54. Russian.

[Clinical Alergology and Immunology: A Guide for Practitioners]. Goryachkinoy LA, Kashkinoy KV, edi­tors. Moskva, Miklosh. 2009;1-432. Russian.

Puhlik BM. [Modern technologies for the treat­ment of allergic diseases]. Zdorove plyus. 2003;2:4-13. Russian.


GOST Style Citations


  1. Аллергический ринит: фармакоэкономические аспекты / А.С. Лопатин, В.И. Петров, Т.А. Слизова, Ю.В. Пономарева // Атмосфера. - 2003. - № 4. – С. 47-50.
  2. Алешина Р. М. Специфическая иммунотера­пия – эффективный метод базисного лечения при ато­пической бронхиальной астме / Р. М. Алешина // Іму­нологія та алергологія. – 1998. – № 1/2. – С. 115-119.
  3. Булгакова В. А. Современные тенденции фар­макотерапии аллергического ринита у детей / В.А. Булгакова, И.И. Балаболкин, Л.Д. Ксензова // Вопросы соврем. педиатрии. – 2007. – Т. 6. – С. 85-91.
  4. Горячкина Л. А. Современные антигистамин­ные препараты в лечении аллергических заболеваний / Л.А. Горячкина // Ринологія. – 2002. – № 1. – С. 70–76.
  5. Гущин И. С. Патофизиология аллергии / И.С. Гу­щин // Рос. ринология. – 2004. – № 1. – С. 6-22.
  6. Дранник Г.Н. Клиническая иммунология и аллергология / Г.Н. Дранник. – Киев: ООО «Полиграф плюс», 2010. – 552 с.
  7. Емельянов А.В. Современные представления о ди­агностике и лечении аллергического ринита / А.В. Емельянов // Лечащий врач.- 2003. – № 3. – С. 4-11.
  8. Зайков С.В. Едины ли подходы к диагностике и лечению аллергического ринита в Украине и стра­нах ЕС? / С.В. Зайков // Клініч. імунологія. Алерго­логія. Інфектологія. – 2007. – № 2. – С. 13-16.
  9. Зайков С.В. Современные представления о лече­нии поллиноза / С. В. Зайков // Клініч. імуно­логія. Алергологія. Інфектологія. – 2008. – № 3 (14). – С. 49-54.
  10. Клиническая алергология и иммунология: ру­ководство для практикуючих врачей / под. ред. Л.А. Го­рячкиной и К.В. Кашкиной. – Москва: Мик­лош, 2009 – 432 с.
  11. Пухлик Б.М. Современные технологии лече­ния аллергических заболеваний / Б.М. Пухлик // Здо­ровье плюс. – 2003. – № 2. – С. 4-13.